Nil Üresin

Nil Üresin

Auto-generated profile, based on publicly available information

Nil Üresin

Technical University of Denmark, Lyngby, Denmark; Biotech Research and Innovation Centre, Faculty of Health Sciences, University of Copenhagen, Denmark; The Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, Faculty of Health Sciences, University of Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
BFBenjamin Furtwängler
Benjamin Furtwängler
NÜNil Üresin
Nil Üresin
KMKhatereh Motamedchaboki
Khatereh Motamedchaboki
RHRomain Huguet
Romain Huguet
DLDaniel Lopez-Ferrer
Daniel Lopez-Ferrer
ESErwin M. Schoof
Erwin M. Schoof
In the young field of single-cell proteomics (scMS), there is a great need for improved global proteome characterization, both in terms of proteins quantified per cell and quantitative performance thereof. The recently introduced real-time search (RTS) on the Orbitrap Eclipse Tribrid mass spectrometer in combination with SPS-MS3 acquisition has been shown to be beneficial for the measurement of samples that are multiplexed using isobaric tags. Multiplexed scMS requires high ion injection times and high-resolution spectra to quantify the single-cell signal; however, the carrier channel facilitates peptide identification and thus offers the opportunity for fast on-the-fly precursor filtering before committing to the time-intensive quantification scan. Here, we compared classical MS2 acquisition against RTS-SPS-MS3, both using the Orbitrap Eclipse Tribrid MS with the FAIMS Pro ion mobility interface and present a new acquisition strategy termed RETICLE (RTS enhanced quant of single cell spectra) that makes use of fast real-time searched linear ion trap scans to preselect MS1 peptide precursors for quantitative MS2 Orbitrap acquisition. We show that classical MS2 acquisition is outperformed by both RTS-SPS-MS3 through increased quantitative accuracy at similar proteome coverage, and RETICLE through higher proteome coverage, with the latter enabling the quantification of over 1000 proteins per cell at an MS2 injection time of 750 ms using a 2 h gradient.

16 October 2025 in Science
Verified
Journal Article
Closed access
BFBenjamin Furtwängler
Benjamin Furtwängler
NÜNil Üresin
Nil Üresin
SRSabrina Richter
Sabrina Richter
MSMikkel Bruhn Schuster
Mikkel Bruhn Schuster
DBDespoina Barmpouri
Despoina Barmpouri
BPBo T. Porse
Bo T. Porse
Single-cell RNA sequencing (scRNA-seq) has facilitated the characterization of cell state heterogeneity and recapitulation of differentiation trajectories. However, the exclusive use of messenger RNA (mRNA) measurements comes at the risk of missing important biological information. We leveraged recent technological advances in single-cell proteomics by mass spectrometry (scp-MS) to generate an scp-MS dataset of an in vivo differentiation hierarchy encompassing >2500 human CD34+ hematopoietic stem and progenitor cells. Through integration with scRNA-seq, we identified proteins important for stem cell function, which were not indicated by their mRNA transcripts. Further, we showed that modeling translation dynamics can infer cell progression during differentiation and explain substantially more protein variation from mRNA than linear correlation. Our work offers a framework for single-cell multiomics studies across biological systems.

5 May 2025 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
VPValdemaras Petrosius
Valdemaras Petrosius
PAPedro Aragon-Fernandez
Pedro Aragon-Fernandez
TATabiwang N. Arrey
Tabiwang N. Arrey
JWJakob Woessmann
Jakob Woessmann
NÜNil Üresin
Nil Üresin
ESErwin M. Schoof
Erwin M. Schoof
Single-cell proteomics by mass spectrometry (scp-MS) holds the potential to provide unprecedented insights into molecular features directly linked to the cellular phenotype, while deconvoluting complex organisms into their basic building blocks. Tailored sample preparation that maximizes the extracted amount of material that is introduced into the mass spectrometer has rapidly propelled the field forward. However, the measured signal is still at the lower edge of detection approaching the sensitivity boundary of current instrumentation. Here, we investigate the capacity of the enhanced sensitivity of the Orbitrap Astral mass spectrometer to facilitate deeper proteome profiles from low-input to single-cell samples. We carry out a comprehensive data acquisition method survey to pinpoint which parameters provide most sensitivity. Furthermore, we explore the quantitative accuracy of the obtained measurements to ensure that the obtained abundances are in line with expected ground truth values. We culminate our technical exploration by generating small datasets from two cultured cell lines and a primary bone marrow sample, to showcase obtainable proteome coverage differences from different source materials. Finally, as a proof of concept we explore protein covariation to showcase how information on known protein complexes is captured inherently in our scp-MS data.

8 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
VPValdemaras Petrosius
Valdemaras Petrosius
PAPedro Aragon-Fernandez
Pedro Aragon-Fernandez
TATabiwang N. Arrey
Tabiwang N. Arrey
NÜNil Üresin
Nil Üresin
BFBenjamin Furtwängler
Benjamin Furtwängler
ESErwin Marten Schoof
Erwin Marten Schoof
The complexity of human physiology arises from well-orchestrated interactions between trillions of single cells in the body. While single-cell RNA sequencing (scRNA-seq) has enhanced our understanding of cell diversity, gene expression alone does not fully characterize cell phenotypes. Additional molecular dimensions, such as proteins, are needed to define cellular states accurately. Mass spectrometry (MS)-based proteomics has emerged as a powerful tool for comprehensive protein analysis, including single-cell applications. However, challenges remain in terms of throughput and proteomic depth, in order to maximize the biological impact of single-cell proteomics by Mass Spectrometry (scp-MS) workflows. This study leverages a novel high-resolution, accurate mass (HRAM) instrument platform, consisting of both an Orbitrap and an innovative HRAM Asymmetric Track Lossless (Astral) analyzer. The Astral analyzer offers high sensitivity and resolution through lossless ion transfer and a unique flight track design. We evaluate the performance of the Thermo Scientific Orbitrap Astral MS using Data-Independent Acquisition (DIA) and assess proteome depth and quantitative precision for ultra-low input samples. Optimal DIA method parameters for single-cell proteomics are identified, and we demonstrate the ability of the instrument to study cell cycle dynamics in Human Embryonic Kidney (HEK293) cells, and cancer cell heterogeneity in a primary Acute Myeloid Leukemia (AML) culture model.

30 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
VPValdemaras Petrosius
Valdemaras Petrosius
PAPedro Aragon-Fernandez
Pedro Aragon-Fernandez
NÜNil Üresin
Nil Üresin
TPTeeradon Phlairaharn
Teeradon Phlairaharn
BFBenjamin Furtwängler
Benjamin Furtwängler
ESErwin M. Schoof
Erwin M. Schoof
Single-cell resolution analysis of complex biological tissues is fundamental to capture cell-state heterogeneity and distinct cellular signaling patterns that remain obscured with population-based techniques. The limited amount of material encapsulated in a single cell however, raises significant technical challenges to molecular profiling. Due to extensive optimization efforts, mass spectrometry-based single-cell proteomics (scp-MS) has emerged as a powerful tool to facilitate proteome profiling from ultra-low amounts of input, although further development is needed to realize its full potential. To this end, we carried out comprehensive analysis of orbitrap-based data independent acquisition (DIA) for limited material proteomics. Notably, we found a fundamental difference between optimal DIA methods for high- and low-load samples. We further improved our low-input DIA method by relying on high-resolution MS1 quantification, thus more efficiently utilizing available mass analyzer time. With our ultra-low input tailored DIA method, we were able to accommodate long injection times and high resolution, while keeping the scan cycle time low enough to ensure robust quantification. Finally, we establish a complete experimental scp-MS workflow, combining DIA with accessible single-cell sample preparation and the latest chromatographic and computational advances and showcase our developments by profiling real single cells.

5 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NÜNil Üresin
Nil Üresin
VPValdemaras Petrosius
Valdemaras Petrosius
PAPedro Aragon-Fernandez
Pedro Aragon-Fernandez
BFBenjamin Furtwängler
Benjamin Furtwängler
ESErwin M. Schoof
Erwin M. Schoof
BPBo T. Porse
Bo T. Porse
Proteins play a key role in defining cellular phenotypes, yet comprehensive proteomic analysis often requires substantial input material, posing challenges in studying rare populations in complex cell systems. Here, we present an accessible, label-free low-input proteomics workflow that allows for comprehensive proteome coverage reminiscent of classical bulk samples from only 500 cells and showcase its application in murine hematopoiesis. With this approach, we construct a proteomic map of hematopoietic stem and progenitor cell (HSPC) populations isolated by fluorescence-activated cell sorting (FACS) from the bone marrow of a single mouse, identifying approximately 7,000 proteins per cell population. Our study recapitulates the differentiation trajectories along the megakaryocytic-erythroid and granulocytic-monocytic lineages. We specifically focus on the dynamics of transcriptional regulators and provide insights into both known and novel population-specific factors. Furthermore, we extend our exploration to the most primitive stem and progenitor compartment, and identify ADP-Ribosyltransferase ART4 (CD297) as a novel cell surface marker that can potentially be used to enrich for long-term hematopoietic stem cells (LT-HSC). The low-input proteomics workflow presented here holds promise for overcoming the challenges associated with analyzing proteomes of rare cell populations, thereby paving the way for broader applications in biomedical research.